2026-10-22
In upstream bioprocess R&D and scale-up for biopharmaceuticals and microbial fermentation, traditional control strategies predominantly focus on external physicochemical parameters such as temperature, pH, dissolved oxygen (DO), and agitation speed. However, these macro-environmental parameters often fail to directly reveal the internal metabolic state of the microorganism.
Without real-time insight into cellular respiration dynamics, process engineers running fed-batch cultivations or scale-up trials frequently encounter substrate inhibition or nutrient starvation due to mismatched feeding profiles. Relying solely on offline sampling introduces significant measurement lag and increases vessel contamination risks. Consequently, evaluating whether a benchtop or pilot bioreactor provides online metabolic rate analytics (OUR/CER/RQ/KLa) has become a critical benchmark under Quality by Design (QbD) bioprocess development framework.
To bridge the gap between process control and microbial physiology, modern automated bioreactor software incorporates real-time upstream bioprocess calculations alongside primary loop control:
When selecting benchtop bioreactors for biopharmaceutical pilot plants and upstream process optimization, process engineers should review the following evaluation criteria:
Send your inquiry directly to us